- Research article
- Open Access
The growth of assisted reproductive treatment-conceived children from birth to 5 years: a national cohort study
BMC Medicine volume 16, Article number: 224 (2018)
Birth weight and early child growth are important predictors of long-term cardiometabolic disease risk, in line with the Developmental Origins of Health and Disease hypothesis. As human assisted reproductive technologies (ARTs) occur during the sensitive periconceptional window of development, it has recently become a matter of urgency to investigate risk in ART-conceived children.
We have conducted the first large-scale, national cohort study of early growth in ART children from birth to school age, linking the register of ART, held by the UK’s Human Fertilisation and Embryology Authority, to Scottish maternity and child health databases.
In this study of 5200 ART and 20,800 naturally conceived (NC) control children, linear regression analysis revealed the birthweight of babies born from fresh embryo transfer cycles is 93.7 g [95% CI (76.6, 110.6)g] less than NC controls, whereas babies born from frozen embryo transfer (FET) cycles are 57.5 g [95% CI (30.7, 86.5)g] heavier. Fresh ART babies grew faster from birth (by 7.2 g/week) but remained lighter (by 171 g), at 6–8 weeks, than NC babies and 133 g smaller than FET babies; FET and NC babies were similar. Length and occipital-frontal circumference followed the same pattern. By school entry (4–7 years), weight, length and BMI in boys and girls conceived by fresh ART and FET were similar to those in NC children.
ART babies born from fresh embryo transfer grow more slowly in utero and in the first few weeks of life, but then show postnatal catch up growth by school age, compared to NC and FET babies. As low birth weight and postnatal catch-up are independent risk factors for cardiometabolic disease over the life-course, we suggest that further studies in this area are now warranted.
More than six million children have been born worldwide since 1978 using assisted reproductive technologies (ART) . While the majority of these appear to be healthy, a higher incidence of some congenital abnormalities, pre-term birth and low birth weight (LBW) for gestational age has been noted among ART singletons [2,3,4,5]. The latter is of increasing concern, since birth weight is a surrogate for fetal growth and a strong predictor of cardiometabolic disease (CMD) risk across the life-course  (the Developmental Origins of Health and Disease (DOHaD); https://dohadsoc.org/)).
Studies in both human populations  and animal models [8, 9] have clearly identified the periconceptional period immediately before and after fertilisation as a unique developmental window during which the long-term health of the individual may be programmed. This has raised significant concerns about ART children as it coincides with the period during which gamete and embryo manipulations take place in the non-physiological ART environment, with specific embryo manipulations associated with altered fetal growth and birth weight .
Postnatal infant and child growth is arguably an even more important indicator of long-term disease risk; in particular, catch-up growth from LBW increases the risk of obesity and CMD [10, 11]. Owing to the lack of routinely collected data, only a limited number of small (≤ 500 children) studies have been carried out on ART child growth and these generally show conflicting results. In three small European cohort studies, children born from intra-cytoplasmic sperm injection (ICSI) were found to be lighter than their target weight (for age and height) at age 3 years, but not at age 5 years . A longitudinal study  noted that ART children had lower weight at birth and 3 months, with similar growth rates to age 3, compared with naturally conceived (NC) subfertile controls. Given the implications of altered early life growth for health risks later in life, it is clearly important to collect definitive data from larger groups of ART children. It is also far from clear which specific ART factors might be causing changes in birth weight, although extending the length of time embryos are kept in culture before (blastocyst) transfer, the type of culture medium and the use of frozen embryo transfer (FET) have been implicated [5, 14,15,16,17]. Without this essential information on modifiable risk factors, it will be impossible to improve the ART process and reduce long-term risk to children.
The UK pioneered ART 40 years ago with the first successful birth in Oldham in July 1978 and thus is home to the first cohort of children now approaching middle age. However, the UK has been among the slowest countries to conduct long-term ART follow-up studies, because the original Human Fertilisation and Embryology Act (1990) did not envisage this. In line with shifts in public opinion, the Act was changed in 2010 and under the principle of presumed consent, the UK now possesses the world’s oldest and largest database of ART available for research, with approximately 110,000 children from 1991 to 2009. However, so far, this has only been exploited for a single cancer follow-up study . There have been no large studies of ART child growth or causal factors in the UK or anywhere in the world. Therefore, the primary aim of this work was to assess the role of ART treatment factors on growth from birth to age of school entry, in a large UK national study. A secondary aim was to provide comparative data for NC babies.
A cohort of ART data from the Human Fertilisation and Embryology Authority (HFEA) register was linked to a series of routinely collected birth and child health records held by the NHS National Services Scotland (NHS NSS) (Fig. 1).
HFEA Assisted Reproductive Technologies Register
The UK has a uniquely comprehensive record of all women who have had ART since August 1991, when it has been compulsory for every UK fertility clinic to report details of all treatments to the HFEA. Up to October 2009, data on 289,000 women and 110,000 children born after treatment has been collected. Data on treatment cycles after October 1, 2009, was not included as, from this time, those undergoing ART were asked to give “consent to disclosure” of identifying information, enabling their records to be used for research. The data relating to children born prior to April 1997 was not included in the study, as they were over the age of 16 at the time of data release and we took a cautious approach as to whether consent had been provided. The HFEA register does not contain a single unique patient identifier, but does contain names and dates of birth.
Scottish Morbidity Record—SMR02
The SMR02 is primarily a source of data on obstetric outcomes, collated from hospital administration records following a woman’s episode of care in an obstetric facility (inpatient and day cases, but not home births). Birth weight, gestational age, Apgar score, occipital-frontal circumference (OFC), length, weight and admission to a neonatal intensive care unit (NICU) have been recorded consistently over time. There is also data on maternal lifestyle with self-reported smoking being consistently recorded. The child’s Community Health Index (CHI) number allows linkage to child data in other datasets.
Scottish child health programme
Data on child growth is available from a number of routine screening programmes. The data consistently collected at 6–8 weeks and on entry to school (generally collected between 4 and 7 years) comprise height (length and OFC at 6–8 weeks), weight, body mass index (BMI) and read-coded health concerns.
In the absence of a unique identifier, HFEA and SMR02 data were linked using probabilistic matching based on maternal names and maternal/child dates-of-birth as described in Additional file 1.
Deprivation was assessed from quintiles of the 2012 Scottish Index of Multiple Deprivation . Maternal smoking history was self-reported.
Birth weight was adjusted for gestational age, gender and (when available) parity (1st baby vs. > 1st baby) using the GROW formula .
Growth velocities were defined as the average change in weight per week (between birth and 6–8 week measurements) or month (between 6 and 8 weeks and school entry).
Numerical outcomes were modelled using linear regression while NICU admission and sex ratio (ratio of female to male births) were modelled using logistic regression. Bootstrapped standard errors (using 1000 replications) are presented. Details of all the models considered are given in Additional file 1: Table S4.
For analyses comparing ART and naturally conceived infants, the primary covariates were deprivation, smoking status, maternal age (fitted as a quadratic function) and an indicator of whether the embryos were from fresh or frozen transfer cycles, plus the matching variables, year and month of delivery and gender. For within ART analyses, we additionally included paternal age (as a quadratic function), use of ICSI, number of previous ART cycles and infertility causes (tubal, endometrial, ovulatory, male and idiopathic as binary indicators) plus treatment centre and year of treatment. As data relating to embryo culture time and number of embryos created were only available on a subset of cases (generally not available for FET cycles), these were not included in the primary analyses, but a secondary analysis including these was conducted. For the analysis of child health programme (CHP) outcomes, we additionally controlled for age at the time of measurement and feed type (breast only, bottle only, breast and bottle) at 10 days post-birth.
In the analysis of NICU admission, the primary analysis was unadjusted for birth weight and gestational age. A secondary analysis was also conducted in which both raw birth weight and gestational age were controlled for.
Using tables of age- and gender-specific L, M and S values , we transformed school-entry weight into deciles of age-standardised z-scores.
All analyses were conducted using STATA (version 14), within the National Safe Haven of Scotland, managed by NHS NSS.
Data linkage and analysis datasets
The linkage process and derivation of the analysis datasets is summarised in Fig. 1.
The resultant dataset comprised 4127 singleton births following fresh ART and 1091 singleton births from FET cycles, along with 20,879 matched NC children. See Additional file 1: Tables S1 and S2 for study characteristics and main outcome variables.
At 6–8 weeks, data was available for 3224 fresh ART births (78%), 812 births following FET (74%) and 15,900 naturally conceived births (76%). The corresponding numbers at school entry were 2095 (51%), 519 (48%) and 10,507 (50%).
The proportions and characteristics of the infants contributing to each of the assessments did not vary between conception groups (Additional file 1: Table S3).
Analyses conducted, outcomes and covariates considered and tables in which corresponding results are presented are summarised in Additional file 1: Table S4.
Newborn health: ART vs. naturally conceived (NC)
To quantify the impact of ART on newborn health, we first compared all ART children to their NC counterparts. Controlling for deprivation, maternal age and maternal smoking status during pregnancy, there was a significant association between each of birth weight (Table 1), OFC and crown-heel length and ART conception (Additional file 1: Table S5).
Compared to NC babies, birth weight was significantly lower in babies born from fresh transfers [-93.7 g; 95% CI (-110.6, -76.6)], but significantly higher from FET [57.5 g; 95% CI (30.7, 86.5)] with an increased incidence of macrosomia (> 4000 g) (17% versus 10% in fresh and 12.6% in NC babies (Additional file 1: Table S2). Similarly, OFC and crown-heel length were smaller in babies born from fresh transfers [-2.87 mm; 95% CI (-3.48, -2.24) and -0.36 cm; 95% CI (-0.50, -0.22) respectively], but larger from FET [1.09 mm; 95% CI (0.06, 2.21) and 0.21 cm; 95% CI (-0.05, 0.47) respectively] (Additional file 1: Table S5).
Compared to NC babies, a significantly shorter gestation was seen in ART babies from both fresh transfers [2.0 days; 95% CI (1.4, 2.5)] and FET [1.2 days; 95% CI (0.3, 2.2)] (Additional file 1: Table S5). This was reflected in a higher rate of pre-term birth (PTB)/very PTB in fresh ART babies (8%/1.3%, compared to 7%/1% and 6%/0.9% in FET and NC babies, respectively: Additional file 1: Table S2). There were no significant differences in sex ratio (Additional file 1: Table S5).
Babies conceived from fresh transfers, but not FET, had a higher rate of admission to NICU [OR = 1.24; 95% CI (1.10, 1.40) for fresh and OR = 1.00; 95% CI (0.80, 1.26) for FET]. However, this effect did not remain when we adjusted for gestation and birth weight (Additional file 1: Table S5).
Fitting similar models for adjusted birth weight, but with time as a linear covariate, revealed no significant temporal trends over the period: NC slope -0.21 g/year; 95%CI (-1.81, 1.57); ART fresh transfers slope 2.59 g/year; 95% CI (-1.12, 6.38); FET slope 0.80 g/year; 95% CI (-6.72, 7.75).
Newborn health: ART treatment variables
Within the ART cohort, we examined the effect of ART treatment factors on birth outcomes (Table 2; Additional file 1: Table S6), controlling for differences in infertility diagnosis, treatment and parity in addition to those factors considered above.
The difference in (adjusted) birth weight between babies from FET, compared to fresh transfer, was estimated as 127.4 g [95% CI (95.0, 162.8)]. Both OFC [by 3.6 cm; 95% CI (2.5, 4.7)] and crown-heel length [by 0.5 cm; 95% CI (0.2, 0.8)] were significantly larger in babies born following FET. There were no significant differences in gestational age, sex ratio or NICU admission (Additional file 1: Table S6). No other IVF factors available had a detectable impact on birthweight, OFC, crown-heel length, gestation, sex ratio or NICU admission (Additional file 1: Table S6).
Infant growth at 6–8 weeks and school entry
Controlling for maternal age, deprivation, smoking and type of feeding, at 6–8 weeks, ART babies from fresh transfers remain smaller than NC babies in respect of their weight [by 171 g; 95% CI (143, 200)], OFC [by 2.41 mm; 95% CI (1.87, 3.05)] and length [by 0.39 cm; 95% CI (0.27, 0.52)], but those from FET show no differences (Fig. 2; Additional file 1: Table S7).
By school entry, we can no longer detect any significant differences in weight between ART and NC children (Fig. 2; Additional file 1: Table S8). However, ART children are very slightly taller [fresh by 0.28 cm; 95% CI (-0.01, 0.53): frozen by 0.68 cm; 95% CI (0.25, 1.13)] and show lower BMI [fresh by -0.12; 95% CI (-0.21, -0.03): frozen by -0.04; 95% CI (-0.022, 0.14)] (Additional file 1: Table S8).
Analysis of ART factors (Additional file 1: Table S9) shows that babies from FET cycles are significantly heavier at 6–8 weeks than those from fresh cycles by 133 g [95% CI (75, 190)] and they tend to remain heavier at school entry, although significance is lost [by 258 g; 95% CI (-116, 651)]. FET babies are significantly taller at school entry [by 0.56 cm; 95% CI (0.07, 1.11)], but no significant difference was seen in BMI. No significant difference in the growth parameters was seen with any of the other ART treatment/diagnosis factors.
Infant growth rates from birth to 6–8 weeks and school entry
We have restricted this analysis to a consideration of weight, which we have for all three time points.
Table 3 shows the linear regression models for growth rate, controlling for gender, deprivation, maternal smoking and age and type of feeding. Babies born from fresh ART grew significantly faster between birth and 6–8 weeks than NC babies, by 7.2 g/week [95% CI (2.1, 12.7)], while babies born from FET were not significantly different. ART-conceived babies grew at a greater rate than NC babies over the period 6–8 weeks to school entry [Fresh vs. NC, 0.25 g/week, 95% CI (-0.34, 0.88); FET vs. NC, 0.74 g/week, 95% CI (-0.39, 1.90)].
No ART-related factors were significantly associated with either growth rate (Additional file 1: Table S10).
Of particular interest is the proportion of infants who show accelerated (‘catch-up’) or decelerated (‘catch-down’) growth (weight) from birth to school entry. In Table 4, we show the numbers who crossed more than one decile in the age/gender adjusted growth charts in the three conception groups. Significantly, more fresh ART babies show catch-up growth from birth to school entry, compared to NC (27% vs. 24%; P = 0.004), but this is not seen in just the smaller babies (lower 3 deciles). Significantly, less catch-down growth is seen in the fresh ART cohort (vs. NC, 23% vs. 27%; P = 0.002) and this is also seen when considering only the largest babies (43% vs. 48%; P = 0.014). FET babies generally show more similar rates of catch-up and catch-down growth to NC babies than to fresh ART babies.
Birth weight and early child growth are important predictors of long-term CMD risk . Although it is well established that ART children are at increased risk of low birth weight, there is little understanding of the causal factors in the ART process and there have been no large studies of postnatal growth in these children. Using the UK ART data register held by the HFEA, linked to maternity and child health data, we conducted a large-scale analysis of more than 5000 singleton ART children. Our key findings are that not only do ART babies born from fresh embryo transfers have lower weights, head circumference and length at birth than NC children, they grow more quickly and catch up by school age. Babies from FET cycles, by contrast, have greater weight, head circumference and length at birth and show similar growth to NC children.
The major strength of this study is the registry-based national cohort design. The loss to follow-up is a concern, although we believe most of this loss is administrative and we could detect no strong biases in those with and without data. The data on NC infants did not include parity and, therefore, we were not able to include this in the birth weight adjustment. It is likely that more NC babies were born to parous women than ART-conceived babies, which would lead to a small, but unquantifiable, over-estimation of birth weight in this group, in turn reducing the effect in ART-Fresh cycles while increasing the effect in FET cycles. Within-ART comparisons were parity-adjusted. Postnatal growth estimates for both ART-conceived and NC children are based on changes and are therefore largely unaffected by parity.
Newborn infants conceived by fresh embryo transfer were smaller than NC infants, with significant differences in birth weight, length and OFC. Some infants were small because they were born early, at gestational ages of < 37 or < 32 weeks, and there were more admissions to the NICU, probably due to conditions associated with prematurity. Other infants were small for gestational age (SGA), which may be due to a slowing down of intrauterine growth, implicating a reduction in placental transfer of nutrients. FET infants by comparison had a higher birth weight, length and OFC than NC infants. The birth weight findings are consistent with previous studies [2, 4, 22], and the weight differences are remarkably consistent across studies, e.g. in a recent prospective RCT in China, FET babies were 161 g larger than fresh ART babies  and in a large Japanese registry study, FET babies were 91 g larger than fresh ART, and 40 g larger than NC babies , very similar findings to ours.
At 6 to 8 weeks of age, the weight, length and OFC of the FET infants and NC infants were similar, while weight, length and OFC in the fresh ART-conceived infants remained smaller. At school entry, weight, length and BMI in the three study groups were similar, showing that low birth weight fresh ART infants, when free from the constraints on intrauterine growth, resume their growth trajectory postnatally and attempt to achieve their genetic potential by catch-up growth. OFC measurements were not available; however, brain growth and somatic growth are likely to be in harmony. The BMI values at school entry were consistent with those reported previously at a similar age.
Previous studies of ART child growth have been small (≤ 500 children) and unable to adequately control for confounding factors, and show conflicting results . In three small European cohort studies, children born from intra-cytoplasmic sperm injection (ICSI) were found to be lighter than their target weight (for age and height) at age 3 years, but not at age 5 years . In a longitudinal study of approximately 200 ART children, they had lower weight at birth and 3 months, with no difference in early growth rate (velocity) compared to a subfertile NC control group; however, ART children then showed greater growth velocity from 3 months to 12 months, followed by similar childhood growth rates to age 3 . Small studies of IVF and ICSI children measured at birth and up to age 18 months in Taiwan , 3 years in the USA , 4 years in the Netherlands  and 10–12 years in the UK  showed few differences in growth . Data from a UK child screening programme  showed that ART children were less likely to be overweight at 5 years old than controls, with significantly lower BMIs at 7 years of age than controls consisting of births after normal conception or to subfertile couples. Green et al.  controlled for embryo freezing as a confounding factor, and showed that fresh transfer IVF children, while lower birthweight than FET or NC children, did not show catch up weight growth in childhood; however, ART conceived girls were taller than matched controls after fresh IVF and also FET [29, 30]. Our data extend this current literature significantly by virtue of the large sample size and careful adjustment for confounding factors, by use of accurate growth data recorded by maternity units including length and OFC in addition to birth weight and, most importantly, by following growth of children to age of school entry.
It is currently unknown what alters fetal and child growth trajectories for children conceived through ART; however, it is noteworthy that the magnitude of impact of ART on birth weight is nearly as great as that of maternal smoking in pregnancy. Catch-up or catch-down growth (centile crossing) after birth are both significant predictors of long-term disease risk. Most LBW children show catch-up growth in the first few months, with accelerated growth associated with increased risk of obesity and CMD risk [11, 31, 32]. Our study shows that fresh ART babies grow faster, from birth, over the first few weeks, than their NC counterparts with further catch-up growth then seen in fresh ART children by school entry age. This is associated, in NC children, with increased risk of obesity and CMD in adulthood [10,11,12, 33, 34] and, in ART children, with greater weight gain during childhood, associated with increased cardiovascular risks . Reassuringly, however, catch-up was not seen in the smallest fresh ART birth weight centiles in our study, whereas the increased rate of catch-down growth observed was strongest for the largest birth weight centile babies.
Our major finding that children born from FET cycles differ significantly in birth weight and child growth from their fresh ART counterparts, strongly implicates some aspect of the ART treatment process itself rather than parental subfertility, as does the animal literature showing that adverse outcomes can be phenocopied in fertile mice subjected to ART . However, the mechanisms involved are unknown. One plausible hypothesis is that the uterine environment is hormonally dysregulated following ovarian hyper-stimulation, such that in fresh cycles fetal growth is restricted due to impaired placental function [5, 35]. Alternatively, the ART environment may act via a direct epigenetic effect on the embryo; however, this would predict that the impaired fetal growth trajectory would be continued into postnatal life, and so is not supported by our data. Fetal growth in FET cycles may also be affected by some aspect of the embryo cryopreservation process, consistent with our previous finding that frozen/thawed embryos show altered gene expression  and our finding (and from others ) that FET babies have a consistently slightly higher birth weight compared to NC babies.
Other than the effects of embryo cryopreservation/FET, we failed to detect any significant associations between newborn or child weight, length and OFC and other ART patient or treatment factors available. However, the HFEA database lacks information on factors such as the type of culture medium embryos were grown in, an important omission in light of recent evidence that culture medium is associated with altered embryo gene expression , epigenetics  and fetal and postnatal growth following ART , resulting in calls for action from professional societies and leading scientific journals .
These longitudinal growth data from a national cohort of more than 5000 ART children identify an increased risk profile for non-communicable disease in later life. ART treatments are constantly evolving, and these studies will need to be replicated in more recent cohorts to capture changes in technology and practice. There is clearly a need to further the research agenda in this area and to take steps to reduce risks from treatment. We call for more detailed studies of the impact of modifiable aspects of IVF on early child growth to reduce risk to the next generation of ART children.
- 95% CI:
(95%) confidence interval
(Low) birth weight
- (NHS) NSS:
(National Health Service) National Services Scotland
(Small for) gestational age
Adjusted birth weight
Assisted reproductive technology/technologies
Body mass index
Community Health Index
Child health programme
Developmental Origins of Health and Disease
Frozen embryo transfer
- GROW (formula):
Gestation-related optimal weight
Human Fertilisation and Embryology Authority
Intra-cytoplasmic sperm injection
Index of Multiple Deprivation
In vitro fertilisation
Neonatal intensive care unit
Occipital frontal circumference
Primary school entry
Randomised controlled trial
Scottish Morbidity Record
Kupka MS, Ferraretti AP, de Mouzon J, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHREdagger. Hum Reprod. 2014;29(10):2099–113.
Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. Bmj. 2004;328(7434):261.
Kamphuis EI, Bhattacharya S, van der Veen F, Mol BW, Templeton A. Evidence Based IVFG. Are we overusing IVF? BMJ. 2014;348:g252.
Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med. 2002;346(10):731–7.
Sunde A, Brison D, Dumoulin J, et al. Time to take human embryo culture seriously. Hum Reprod. 2016;31(10):2174–82.
Barker DJ. Intrauterine programming of adult disease. Mol Med Today. 1995;1(9):418–23.
Roseboom TJ, Painter RC, van Abeelen AF, Veenendaal MV, de Rooij SR. Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas. 2011;70(2):141–5.
Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development. 2000;127(19):4195–202.
Vrooman LA, Bartolomei MS. Can assisted reproductive technologies cause adult-onset disease? Evidence from human and mouse. Reprod Toxicol. 2017;68:72–84.
Martin A, Connelly A, Bland RM, Reilly JJ. Health impact of catch-up growth in low-birth weight infants: systematic review, evidence appraisal, and meta-analysis. Matern Child Nutr. 2017;13(1).
Kerkhof GF, Hokken-Koelega AC. Rate of neonatal weight gain and effects on adult metabolic health. Nat Rev Endocrinol. 2012;8(11):689–92.
Hart R, Norman RJ. The longer-term health outcomes for children born as a result of IVF treatment: part I--general health outcomes. Hum Reprod Update. 2013;19(3):232–43.
Ceelen M, van Weissenbruch MM, Prein J, et al. Growth during infancy and early childhood in relation to blood pressure and body fat measures at age 8-18 years of IVF children and spontaneously conceived controls born to subfertile parents. Hum Reprod. 2009;24(11):2788–95.
Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update. 2018;24(1):35–58.
Kleijkers SH, Mantikou E, Slappendel E, et al. Influence of embryo culture medium (G5 and HTF) on pregnancy and perinatal outcome after IVF: a multicenter RCT. Hum Reprod. 2016;31(10):2219–30.
Chen ZJ, Shi Y, Sun Y, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375(6):523–33.
Belva F, Henriet S, Van den Abbeel E, et al. Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum Reprod. 2008;23(10):2227–38.
Williams CL, Bunch KJ, Stiller CA, et al. Cancer risk among children born after assisted conception. N Engl J Med. 2013;369(19):1819–27.
The Scottish Index of Multiple Deprivation. 2017. http://www.gov.scot/Topics/Statistics/SIMD. Accessed 01/06/2017.
Gardosi J, Francis A. GROW documentation. 2015. www.gestation.net/GROW_documentation.pdf. Accessed 12/1/17 2017.
Cole TJ. The development of growth references and growth charts. Ann Hum Biol. 2012;39(5):382–94.
Wennerholm UB, Henningsen AK, Romundstad LB, et al. Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Hum Reprod. 2013;28(9):2545–53.
Nakashima A, Araki R, Tani H, et al. Implications of assisted reproductive technologies on term singleton birth weight: an analysis of 25,777 children in the national assisted reproduction registry of Japan. Fertil Steril. 2013;99(2):450–5.
Lee SH, Lee MY, Chiang TL, Lee MS, Lee MC. Child growth from birth to 18 months old born after assisted reproductive technology--results of a national birth cohort study. Int J Nurs Stud. 2010;47(9):1159–66.
Yeung EH, Sundaram R, Bell EM, et al. Infertility treatment and children's longitudinal growth between birth and 3 years of age. Hum Reprod. 2016;31(7):1621–8.
Woldringh GH, Hendriks JC, van Klingeren J, et al. Weight of in vitro fertilization and intracytoplasmic sperm injection singletons in early childhood. Fertil Steril. 2011;95(8):2775–7.
Basatemur E, Shevlin M, Sutcliffe A. Growth of children conceived by IVF and ICSI up to 12 years of age. Reprod BioMed Online. 2010;20(1):144–9.
Sutcliffe AG, Melhuish E, Barnes J, Gardiner J. Health and development of children born after assisted reproductive technology and sub-fertility compared to naturally conceived children: data from a national study. Pediatr Rep. 2014;6(1):5118.
Green MP, Mouat F, Miles HL, et al. Phenotypic differences in children conceived from fresh and thawed embryos in in vitro fertilization compared with naturally conceived children. Fertil Steril. 2013;99(7):1898–904.
Miles HL, Hofman PL, Peek J, et al. In vitro fertilization improves childhood growth and metabolism. J Clin Endocrinol Metab. 2007;92(9):3441–5.
Belfort MB, Rifas-Shiman SL, Rich-Edwards J, Kleinman KP, Gillman MW. Size at birth, infant growth, and blood pressure at three years of age. J Pediatr. 2007;151(6):670–4.
Fleming TP, Watkins AJ, Velazquez MA, et al. Origins of lifetime health around the time of conception: causes and consequences. Lancet. 2018;391(10132):1842–52.
Fabricius-Bjerre S, Jensen RB, Faerch K, et al. Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence. PLoS One. 2011;6(6):e20595.
Sheng X, Tong M, Zhao D, et al. Randomized controlled trial to compare growth parameters and nutrient adequacy in children with picky eating behaviors who received nutritional counseling with or without an oral nutritional supplement. Nutr Metab Insights. 2014;7:85–94.
Sibley C, D'Souza S, Glazier J, Greenwood S. Mechanisms of solute transfer across the human placenta: effects of intrauterine growth restriction. Fetal Matern Med Rev. 1998;10(4):197–206.
The authors gratefully acknowledge the considerable and vital roles of both the Human Fertilisation and Embryology Authority and NHS National Services Scotland in the conduct of this research. In particular, David Moysen, Nick Jones, Howard Ryan, Suzanne Hodgson and Deborah Bloor from the HFEA, who maintain the Assisted Reproductive Technology Register and facilitated its secure transfer to the National Safe Haven for Scotland and Jim Chalmers, Dave Clark, David Bailey, John Nolan, Carole Morris, Andy Duffy and Doug Kidd from NHS NSS who provided the Safe Haven as a platform for data storage and analysis, conducted the data linkage, monitored study outputs and replied to numerous and varied queries relating to all aspects of study conduct and logistics.
This work was funded by a grant from the European Union, FP7-HEALTH-2011-TWO-STAGE-278418, EPIHEALTH.
Availability of data and materials
The data that support the findings of this study are available from The Human Fertilisation and Embryology Authority and NHS National Services Scotland but restrictions apply to the availability of these data, which were used under licence for the current study, and so are not publicly available.
Ethics approval and consent to participate
Ethical approval was granted by the Greater Manchester Central NHS Ethics Committee on September the 11th 2013 (Ref: 13/NW/0585).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Hann, M., Roberts, S.A., D’Souza, S.W. et al. The growth of assisted reproductive treatment-conceived children from birth to 5 years: a national cohort study. BMC Med 16, 224 (2018). https://doi.org/10.1186/s12916-018-1203-7
- Assisted reproductive technology
- Birth weight
- Child growth
- Data linkage